Merrimack Pharmaceuticals (NASDAQ:MACK) Stock Crosses Above

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK – Get Rating)’s stock price crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $9.67 and traded as high as $12.66. Merrimack Pharmaceuticals shares last traded at $12.51, with a volume of 63,141 shares trading hands. Analysts […]

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , Massachusetts , United States , Eric Andersen , Geode Capital Management , Merrimack Pharmaceuticals , Merrimack Pharmaceuticals Trading , Securities Exchange Commission , Merrimack Pharmaceuticals Inc , News Ratings For Merrimack Pharmaceuticals Daily , Boothbay Fund Management , Insider Activity At Merrimack Pharmaceuticals , Nasdaq , Get Rating , Director Eric Andersen , Exchange Commission , Director Noah , Capital Management , Fund Management , Two Sigma Investments , Sigma Investments , Merrimack Pharmaceuticals Daily , Nasdaq Mack , Smack , Medical , 59032810 , Stocks , Technicals ,